Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients
Reed B. Hogan, Reed B. Hogan, Tim Cannon, Maria Rappai, John Studdard, Doug Paul, Thomas P. Dooley
Topics & Concepts
CetirizineFamotidineBlockadeMedicineCoronavirus disease 2019 (COVID-19)Histamine H2 receptorHistamineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakAnesthesiaCimetidinePharmacologyReceptorInternal medicineVirologyAntagonistInfectious disease (medical specialty)DiseaseOutbreakUrticaria and Related ConditionsPharmacological Receptor Mechanisms and EffectsLong-Term Effects of COVID-19